Our previous study with 340 BA patients and 1665 controls investigated the four reported GWAS loci including ADD3, GPC1, ARF6 and EFEMP1, which validated the association of ADD3 variants with study-wide significance and the association of GPC1 variants with nominal significance [15]. This evidence concerns the gene ARF6 and breast angiosarcoma.